Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm
NCT06657066
EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA
EFFECTIVENESS of PROBIOTIC AS an ADJUVANT to STANDARD THERAPY VERSUS STANDARD THERAPY ALONE in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA
Sponsor: King Edward Medical University
Conditions
Asthma Patients
Interventions
Beclomethasone 200mcg, salbutamol 100mcg , Beclomethasone 200 mcg/Formoterol 6 mcg, 250 mg of lyophilized saccharomyces boulardii Control (Standard treatment)
Updated 1 time since 2024 Last updated: Oct 22, 2024 Started: Dec 6, 2021 Primary completion: Apr 24, 2022 Completion: Aug 8, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2/PHASE3 trial investigates Asthma Patients and is currently completed. King Edward Medical University leads this study, which shows 1 recorded version since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Completed — PHASE2/PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- King Edward Medical University
Data source: King Edward Medical University
For direct contact, visit the study record on ClinicalTrials.gov .